undefined
The trademark application H-Apyzil was filed by Portus Pharma, a corporation established under the laws of the Portuguese Republic (the "Applicant"). The application was published for oppositions on April 3, 2023, and it was registered by office on July 11, 2023 without any oppositions.
The application was filed in Portuguese (English was selected as the second language).